Oxford Biomedica Solutions
Stacia (Hogle) Dubois is an experienced professional in the engineering field with a focus on process engineering and management. Currently serving as Engineering Manager at Oxford Biomedica since August 2022, Stacia previously held positions including Senior Process Engineer at Homology Medicines, Inc., Process Engineer at IPS-Integrated Project Services, LLC, and Process Equipment Engineer at Genzyme. Stacia also worked as a Quality/SPC Engineer/Process Engineer at Dow Chemical and served as an Office Assistant while pursuing a Bachelor of Science in Chemical Engineering at the University of New Hampshire from 2007 to 2012.
Oxford Biomedica Solutions
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.